The genetic underpinnings of MS, primarily rooted in mutations of the FBN1 gene, introduce a fundamental alteration in the composition of the extracellular matrix and its intricate dance with transforming growth factor-beta (TGFβ). The gene discussed is FBN1; the disease is myeloid sarcoma.